Published in Bioconjug Chem on November 19, 2003
Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev (2008) 4.80
Noninvasive cell-tracking methods. Nat Rev Clin Oncol (2011) 2.26
Multimodal MRI contrast agents. J Biol Inorg Chem (2007) 1.86
Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol (2010) 1.75
Nanoparticle imaging of integrins on tumor cells. Neoplasia (2006) 1.70
Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging. Small (2009) 1.64
Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials (2010) 1.42
Nanoparticles for applications in cellular imaging. Nanoscale Res Lett (2007) 1.34
Molecular imaging for personalized cancer care. Mol Oncol (2012) 1.28
Exogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-modal Imaging. Cancers (Basel) (2010) 1.24
Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets. Proc Natl Acad Sci U S A (2011) 1.23
Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI. J Biol Inorg Chem (2008) 1.20
Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells. Stem Cells (2007) 1.04
Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking. Biomaterials (2009) 1.02
Nanomedicine strategies for molecular targets with MRI and optical imaging. Future Med Chem (2010) 0.99
Slow self-activation enhances the potency of viridin prodrugs. J Med Chem (2008) 0.99
Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media. J Am Chem Soc (2009) 0.96
TAT peptide and its conjugates: proteolytic stability. Bioconjug Chem (2009) 0.95
Oxazine conjugated nanoparticle detects in vivo hypochlorous acid and peroxynitrite generation. J Am Chem Soc (2009) 0.95
Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting. J Leukoc Biol (2011) 0.95
Aliphatic hyperbranched polyester: a new building block in the construction of multifunctional nanoparticles and nanocomposites. Langmuir (2010) 0.91
Investigation of folate-conjugated fluorescent silica nanoparticles for targeting delivery to folate receptor-positive tumors and their internalization mechanism. Int J Nanomedicine (2011) 0.88
Labelling of mammalian cells for visualisation by MRI. Eur Radiol (2009) 0.88
The assembly state between magnetic nanosensors and their targets orchestrates their magnetic relaxation response. J Am Chem Soc (2011) 0.87
Quantitative cardiovascular magnetic resonance for molecular imaging. J Cardiovasc Magn Reson (2010) 0.84
Tat peptide is capable of importing large nanoparticles across nuclear membrane in digitonin permeabilized cells. Ann Biomed Eng (2009) 0.81
Identification of molecular-mimicry-based ligands for cholera diagnostics using magnetic relaxation. Bioconjug Chem (2011) 0.80
Cellular magnetic resonance imaging: potential for use in assessing aspects of cardiovascular disease. Cytotherapy (2008) 0.78
Selective N-alkylation of β-alanine facilitates the synthesis of a poly(amino acid)-based theranostic nanoagent. Biomacromolecules (2011) 0.78
In vivo imaging of transplanted hepatocytes with a 1.5-T clinical MRI system--initial experience in mice. Eur Radiol (2007) 0.78
Bioabsorbable stent quo vadis: a case for nano-theranostics. Theranostics (2014) 0.77
Molecular MR Imaging Probes. Proc IEEE Inst Electr Electron Eng (2005) 0.75
Cardiac-targeting magnetic lipoplex delivery of SH-IGF1R plasmid attenuate norepinephrine-induced cardiac hypertrophy in murine heart. Biosci Rep (2014) 0.75
Formulation of long-wavelength indocyanine green nanocarriers. J Biomed Opt (2017) 0.75
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
A clearer vision for in vivo imaging. Nat Biotechnol (2001) 10.49
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol (2000) 6.90
Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle. J Biol Chem (1977) 5.16
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem (1999) 4.41
In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med (2001) 4.30
A characterization of vanadate interactions with the (Na,K)-ATPase. Mechanistic and regulatory implications. J Biol Chem (1978) 3.67
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology (1990) 3.50
Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized Born approximation. Opt Lett (2001) 3.43
Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med (1993) 3.01
Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn Reson Med (1998) 2.98
Hand positions and the "son-of-Doughty" technique. Anaesthesia (2005) 2.36
Long term backache after childbirth: prospective search for causative factors. BMJ (1996) 2.27
Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology (2001) 2.24
Molecular imaging: exploring the next frontier. Radiology (1999) 2.19
Back pain, pregnancy, and childbirth. BMJ (1997) 2.14
In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res (2000) 2.12
Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology (2000) 2.11
Isolation of a potent (Na-K)ATPase inhibitor from striated muscle. Biochemistry (1977) 2.07
Self-poisoning and self-injury in the Oxford area. Epidemiological aspects 1969-73. Br J Prev Soc Med (1975) 2.06
Assessing long term backache after childbirth. BMJ (1993) 2.03
Dural puncture and headache. BMJ (1993) 2.01
Near-infrared optical imaging of protease activity for tumor detection. Radiology (1999) 1.97
Ocular and cardiovascular effects of local and systemic pindolol. Br J Ophthalmol (1979) 1.81
Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging (1998) 1.77
Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology (1990) 1.75
Sciatic nerve palsy following childbirth. Anaesthesia (1996) 1.71
Silk fibroin as an organic polymer for controlled drug delivery. J Control Release (2006) 1.71
A simple technique to reduce the incidence of accidental dural puncture. Anaesthesia (2001) 1.71
Improvement of MRI probes to allow efficient detection of gene expression. Bioconjug Chem (2000) 1.70
Fluorescence molecular imaging of small animal tumor models. Curr Mol Med (2004) 1.62
Logic in the safe practice of spinal anaesthesia. Anaesthesia (2000) 1.61
Paramagnetic metal scavenging by melanin: MR imaging. Radiology (1997) 1.60
Processing of the 5' end of Escherichia coli 16S ribosomal RNA. Proc Natl Acad Sci U S A (1978) 1.59
People who deliberately poison or injure themselves: their problems and their contacts with helping agencies. Psychol Med (1977) 1.59
Extradural opioids in labour. Br J Anaesth (1989) 1.57
Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjug Chem (1999) 1.56
Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Roentgenol (2001) 1.53
Toxicity of norpethidine in sickle cell crisis. BMJ (1992) 1.52
Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. J Immunol Methods (2001) 1.51
Ethics and clinical research in obstetric anaesthesia. Lancet (1992) 1.51
Ultrasound venous access simulation: the Italian job. Emerg Med J (2009) 1.49
MR imaging of gene delivery to the central nervous system with an artificial vector. Radiology (1998) 1.49
Human transferrin receptor gene as a marker gene for MR imaging. Radiology (2001) 1.48
Developmental changes in cortisol secretion in normal and at-risk youth. Dev Psychopathol (2001) 1.48
Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. J Struct Biol (1995) 1.47
The Venus flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors. AAPS PharmSci (1999) 1.47
Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology (1988) 1.46
Can pre-emptive lumbar epidural blockade reduce postoperative pain following lower abdominal surgery? Anaesthesia (1993) 1.46
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J Control Release (2001) 1.45
Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Lancet (1976) 1.43
Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging (1999) 1.42
Life-saving or ineffective? An observational study of the use of cricoid pressure and maternal outcome in an African setting. Int J Obstet Anesth (2009) 1.42
The effects of maternal epidural anaesthesia on neonatal behaviour during the first month. Dev Med Child Neurol (1994) 1.41
Maternal sequelae of childbirth. Br J Anaesth (1995) 1.41
Silk based biomaterials to heal critical sized femur defects. Bone (2006) 1.40
The effect of epidural opioids on maternal oxygenation during labour and delivery. Anaesthesia (1996) 1.39
Assessing bupivacaine 10 mg/fentanyl 20 microg as an intrathecal test dose. Int J Obstet Anesth (2003) 1.39
Ropivacaine. Anaesthesia (1991) 1.38
Mouse models of human non-small-cell lung cancer: raising the bar. Cold Spring Harb Symp Quant Biol (2005) 1.37
The effect of anaesthesia of the airway in dog and man: a study of respiratory reflexes, sensations and lung mechanics. Clin Sci Mol Med (1976) 1.36
In vivo imaging of gene expression:. Acad Radiol (2001) 1.36
Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes. Diabetes (2001) 1.34
A comparison of the potential toxicity of bupivacaine, lignocaine and mepivacaine during epidural blockade for surgery. Br J Anaesth (1971) 1.33
A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology (1993) 1.32
Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta (1998) 1.31
Effect of scaffold design on bone morphology in vitro. Tissue Eng (2006) 1.28
Molecular imaging of gene therapy for cancer. Gene Ther (2004) 1.28
Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology (1988) 1.25
Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjug Chem (2000) 1.25
BMP-silk composite matrices heal critically sized femoral defects. Bone (2007) 1.22
MR imaging of phagocytosis in experimental gliomas. Radiology (1995) 1.20
The development of in vivo imaging systems to study gene expression. Trends Biotechnol (1998) 1.19
Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques (1998) 1.18
Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics. J Control Release (1999) 1.16
A controlled trial of extradural fentanyl in labour. Br J Anaesth (1982) 1.11
Interfacial adsorption and aggregation associated changes in secondary structure of human calcitonin monitored by ATR-FTIR spectroscopy. Biochemistry (1994) 1.10
Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. Radiographics (1998) 1.10
Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomes. Biochim Biophys Acta (1994) 1.10
Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin. Eur J Cancer (2000) 1.10
Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined. Br J Clin Pharmacol (1984) 1.07
Logical approach to lignocaine therapy. Br Med J (1976) 1.07
Comparison of the vasoactivity of amide and ester local anaesthetics. An intradermal study. Br J Anaesth (1985) 1.07
Risk information supplied by obstetric anaesthetists in Britain and Ireland to mothers awaiting elective caesarean section. Int J Obstet Anesth (1995) 1.06
Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy. Br Med J (Clin Res Ed) (1982) 1.06
Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosurgery (1994) 1.05
The effect of concentration on vasoactivity of bupivacaine and lignocaine. Br J Anaesth (1976) 1.05
Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging. AJR Am J Roentgenol (1998) 1.05
Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Invest Radiol (1995) 1.04
In vivo imaging of gene and cell therapies. Exp Hematol (2001) 1.03
Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters. Biopharm Drug Dispos (2003) 1.03
Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesis. Microvasc Res (1998) 1.03
Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain. Am J Pathol (1995) 1.03
A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. Vaccine (1995) 1.02
Primary liver tumors: diagnosis by MR imaging. AJR Am J Roentgenol (1989) 1.02
Magnetic sensing technology for molecular analyses. Lab Chip (2014) 1.01